Based on the knowledge discussed in the previous sections, we propose a putative model of the mechanisms through which cDC1 promote the rejection of syngeneic tumor grafts in preclinical mouse models (Table 2) and may physiologically contribute to cancer immunosurveillance (Figure 2). Here, MPPE1 is linked to cancer.